J&J Unit Hit With Suit Over Rheumatoid Arthritis Drug
By Matt Fair (November 19, 2013, 7:55 PM EST) -- An Indiana coupled filed suit in Pennsylvania court Friday alleging that a Johnson & Johnson unit failed to adequately warn doctors and the public about the risks of nerve paralysis associated with its rheumatoid arthritis drug Remicade.
In a complaint lodged in the Philadelphia County Court of Common Pleas, Linda and Charles Snyder allege that Janssen Biotech Inc. knew that the drug carried a significant risk of medical problems including numbness, memory loss and fibromyalgia, but that it failed to adequately convey warnings to prescribing physicians and regulators with the U.S. Food and Drug Administration.
"Plaintiffs alleged that at all relevant...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!